IVERIC bio (ISEE) Reports In-Line Q1 EPS

IVERIC bio (NASDAQ: ISEE) reported Q1 EPS of ($0.29), in-line with the analyst estimate of ($0.29). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on IVERIC bio (ISEE) click here.

You May Also Be Interested In

• ASML Holdings (ASML) Tops Q2 EPS by 59c; offers guidance
• Kestra Medical Technologies, Ltd. (KMTS) Misses Q2 EPS by 9c, Beats on Revenue
• IBM plunges 19% as memory capex squeeze derails Q2 earnings